Shares of Bio-Techne Corp. TECH advanced 3.23% to $73.79 Friday, on what proved to be an all-around favorable trading session ...

This was the stock's fourth consecutive day of losses.

Bio-Techne Corporation (TECH), headquartered in Minneapolis, Minnesota, develops, manufactures, and sells life science ...

Bio-Techne Corporation TECH recently announced a co-marketing and co-promotion agreement with Waters Corporation. The latest ...

Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight ratings firms that are covering the stock, Marketbeat.com reports.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bio-Techne Corporation (TECH), headquartered in ... Wall Street analysts are bullish on TECH’s prospects. The stock has a consensus “Strong Buy” rating from the 13 analysts covering it ...

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments ...

TECH Stock Likely to Gain From the Development Since the announcement on Dec. 10, Bio-Techne’s shares dipped 0.4%, closing at $76.81 in yesterday’s session. On a promising note, Bio-Techne’s deep ...